Erectile dysfunction in spinal cord injury: a cost-utility analysis

By Mittmann Nicole   Craven B.   Gordon Michael   Macmillan D.H.   Hassouna Magdy   Raynard Warren   Kaiser Anita   Lanctôt L.   Tarride Jean-Eric  

Journal of Rehabilitation Medicine, Vol. 37, Iss. 6, 2005-11 ,pp. : 358-364

Medical Journals Limited

Access to resources Recommend Favorite

A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

By Armstrong Edward P.   Malone Daniel C.   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1115-1121

Informa Healthcare

Access to resources Recommend Favorite

A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus

By Swift James A.   Conway Peter   Purdie David W.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2051-2061

Informa Healthcare

Access to resources Recommend Favorite

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes

By Palmer Andrew J.   Dinneen Sean   Gavin James R.   Gray Alastair   Herman William H.   Karter Andrew J.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 861-872

Informa Healthcare

Access to resources Recommend Favorite

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

By Kielhorn Adrian   Porter Duncan   Diamantopoulos Alexander   Lewis Gavin  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2639-2650

Informa Healthcare

Access to resources Recommend Favorite